These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18242480)

  • 1. Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.
    Toyama T; Hoshizaki H; Yoshimura Y; Kasama S; Isobe N; Adachi H; Oshima S; Taniguchi K
    J Nucl Cardiol; 2008; 15(1):57-64. PubMed ID: 18242480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.
    Koracevic G
    J Nucl Cardiol; 2008; 15(4):604. PubMed ID: 18674729
    [No Abstract]   [Full Text] [Related]  

  • 3. To add amiodarone or not: that is the question.
    Zimmerman MJ; Gerson MC
    J Nucl Cardiol; 2008; 15(1):7-9. PubMed ID: 18242473
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Add-on Therapy with Carvedilol and the Direct Renin Inhibitor Aliskiren for Improving Cardiac Sympathetic Nerve Activity, Cardiac Function, Symptoms, Exercise Capacity and Brain Natriuretic Peptide in Patients with Dilated Cardiomyopathy.
    Toyama T; Kasama S; Miyaishi Y; Kan H; Yamashita E; Kawaguchi R; Adachi H; Hoshizaki H; Ohshima S
    Ann Nucl Cardiol; 2021; 7(1):33-42. PubMed ID: 36994133
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
    Tsuda E; Matsuo M; Sakaguchi H; Hayashi T; Hosoda K; Miyazaki A
    Pediatr Int; 2010 Feb; 52(1):e39-42. PubMed ID: 20158646
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
    Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
    J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.
    Inoue A; Yamashina S; Yamazaki J
    Ann Nucl Med; 2003 Dec; 17(8):677-83. PubMed ID: 14971610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Cardiol; 2004; 11(2):134-41. PubMed ID: 15052244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
    Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
    Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy.
    Oflaz MB; Balli S; Kibar AE; Ece I; Akdeniz C; Tuzcu V
    Med Sci Monit; 2013 May; 19():366-72. PubMed ID: 23686300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
    Cice G; Tagliamonte E; Ferrara L; Iacono A
    Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
    Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.